Home Data Calendar Blog

STOK

Tables

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Common Stock Value 0.000.000.000.000.000.000.00
Weighted Average Number Of Diluted Shares Outstanding 44.2744.1942.54NA39.2639.2637.45
Weighted Average Number Of Shares Outstanding Basic 44.2744.1942.54NA39.4239.2637.45
Weighted Average Number Of Share Outstanding Basic And Diluted NANANANANANA37.45
Earnings Per Share Basic -0.55-0.69-0.53-0.65-0.66-0.63-0.66
Earnings Per Share Diluted -0.55-0.69-0.53-1.31-0.63-0.63-0.66
Earnings Per Share Basic And Diluted NANANANANANA-0.66

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Revenues 3.31-2.485.153.272.903.233.00
Operating Expenses 30.5430.7829.8430.4430.0528.4727.80
Research And Development Expense 20.2720.5519.6321.0620.1118.3618.31
General And Administrative Expense 10.2710.2310.219.389.9410.119.49
Operating Income Loss -27.23-33.26-24.69-27.18-27.15-25.24-24.80
Interest Income Expense Nonoperating Net 2.652.572.101.480.990.540.10
Allocated Share Based Compensation Expense 6.556.765.895.845.936.164.97
Profit Loss -24.54-30.65-22.55-25.66-26.11-24.65-24.65
Other Comprehensive Income Loss Net Of Tax 0.230.220.580.53-0.43-0.59-0.52
Net Income Loss -24.54-30.65-22.55-25.66-26.11-24.65-24.65
Comprehensive Income Net Of Tax -24.31-30.43-21.97-25.13-26.54-25.24-25.16

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Assets 239.89256.92281.80256.07277.63301.43315.94
Liabilities 66.8966.7267.9771.2273.4877.1175.96
Liabilities And Stockholders Equity 239.89256.92281.80256.07277.63301.43315.94
Stockholders Equity 173.00190.19213.82184.85204.14224.32239.98

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Assets Current 230.02246.23270.24244.07264.60289.16305.77
Cash And Cash Equivalents At Carrying Value 189.98192.06190.34113.56113.4067.7584.11
Other Assets Current 4.273.705.882.96NANANA
Prepaid Expense And Other Assets Current NANANANA12.5513.1812.29

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Property Plant And Equipment Gross NANANA10.88NANANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment NANANA4.21NANANA
Property Plant And Equipment Net 6.226.476.796.677.165.875.04
Available For Sale Debt Securities Amortized Cost Basis 24.8939.7763.93117.21139.96209.15209.79

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Liabilities Current 25.2021.8431.5331.3928.8027.6522.91
Accounts Payable Current 3.081.564.300.771.913.603.33
Other Liabilities Current 0.470.700.510.510.430.750.52

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Liabilities Noncurrent 41.6944.8936.4539.8244.6949.4653.06
Other Liabilities Noncurrent 0.961.632.302.973.614.253.51
Operating Lease Liability Noncurrent 0.821.462.092.723.323.913.13

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Stockholders Equity 173.00190.19213.82184.85204.14224.32239.98
Common Stock Value 0.000.000.000.000.000.000.00
Additional Paid In Capital 548.03540.92534.11483.17477.34470.98461.39
Retained Earnings Accumulated Deficit -374.89-350.35-319.69-297.15-271.50-245.38-220.73
Accumulated Other Comprehensive Income Loss Net Of Tax -0.15-0.38-0.60-1.18-1.70-1.28-0.68
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 6.556.765.89NA5.936.164.97

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Net Cash Provided By Used In Operating Activities -17.26-21.80-21.36-22.37-22.06-19.9332.49
Net Cash Provided By Used In Investing Activities 14.6223.4753.0922.4967.260.15-135.78
Net Cash Provided By Used In Financing Activities 0.560.0545.050.040.433.4242.51

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Net Cash Provided By Used In Operating Activities -17.26-21.80-21.36-22.37-22.06-19.9332.49
Net Income Loss -24.54-30.65-22.55-25.66-26.11-24.65-24.65
Profit Loss -24.54-30.65-22.55-25.66-26.11-24.65-24.65
Share Based Compensation 6.556.765.895.795.936.164.97

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Net Cash Provided By Used In Investing Activities 14.6223.4753.0922.4967.260.15-135.78
Payments To Acquire Property Plant And Equipment 0.380.840.170.412.030.680.84

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Net Cash Provided By Used In Financing Activities 0.560.0545.050.040.433.4242.51

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Revenues 3.31-2.485.153.272.903.233.00
Acadia Pharmaceuticals Inc 3.30NANANANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Other Nonoperating Income Expense
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Operating Lease Right Of Use Asset
Current Assets
Other Assets Current
NonCurrent Assets
Operating Lease Right Of Use Asset
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Operating Lease Liability
Current Liabilities
Other Liabilities Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Property Plant And Equipment
Shares
Weighted Average Number Of Share Outstanding Basic And Diluted
OperatingLeaseLiability
Operating Lease Liability Noncurrent
NonoperatingIncomeExpense
Other Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Undiscounted Excess Amount

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:FinancialInstrument
(None,)
Available For Sale Debt Securities Amortized Cost Basisus-gaap: Financial Instrument
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components